DELIVERING HEALTH INFORMATION
YOU CAN TRUST SINCE 1989
Join the enews community - Terms
MEMBER
MENU
Filter by Categories
Blog
General
Lifestyle

New diabetes drug makes the problem worse

Reading time: 1 minute

The injectable drug, produced by Novo Nordisk, was approved around six years ago because it successfully lowered blood sugar levels almost immediately. But it came with serious risks: the US’s drug regulator, the Food and Drug Administration (FDA), warned that the drug increased the risk of thyroid cancer. Common side effects, such as nausea, vomiting and diarrhea, have also made the drug difficult to take.

And now researchers from the Karolinksa Institute in Sweden have also discovered that any benefits are short-lived; after 250 days, or 35 weeks, the drug impairs the body’s already-compromised ability to produce insulin.

Their research has thus far been restricted to tests on laboratory mice, but they say the evidence is sufficient for doctors to be aware of the risk and monitor the health of their patients.

Liraglutide is a blood-sugar suppressing GLP-1 analogue.

(Source: Cell Metabolism, 2016; doi: 10.1016/j.cmet.2016.01.009)

What do you think? Start a conversation over on the... WDDTY Community

  • Recent Posts

  • Copyright © 1989 - 2024 WDDTY
    Publishing Registered Office Address: Hill Place House, 55a High Street Wimbledon, London SW19 5BA
    Skip to content